Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.
The observed heterogeneity in rubella-specific immune response phenotypes post-MMR vaccination is thought to be explained, in part, by inter-individual genetic variation. In this study, single nucleotide polymorphisms (SNPs) and multiple haplotypes in several candidate genes were analyzed for associations with more than one rubella-specific immune response outcome, including secreted IFN-γ, secreted IL-6, and neutralizing antibody titers. Overall, we identified 23 SNPs in 10 different genes that were significantly associated with at least two rubella-specific immune responses. Of these SNPs, we detected eight in the PVRL3 gene, five in the PVRL1 gene, one in the TRIM22 gene, two in the IL10RB gene, two in the TLR4 gene, and five in other genes (PVR, ADAR, ZFP57, MX1, and BTN2A1/BTN3A3). The PVRL3 gene haplotype GACGGGGGCAGCAAAAAGAAGAGGAAAGAACAA was significantly associated with both higher IFN-γ secretion (t-statistic 4.43, p < 0.0001) and higher neutralizing antibody titers (t-statistic 3.14, p = 0.002). Our results suggest that there is evidence of multigenic associations among identified gene SNPs and that polymorphisms in these candidate genes contribute to the overall observed differences between individuals in response to live rubella virus vaccine. These results will aid our understanding of mechanisms behind rubella-specific immune response to MMR vaccine and influence the development of vaccines in the future.
Mayo Clinic Vaccine Research Group, Mayo Clinic, Guggenheim 611C, 200 1st Street S.W., Rochester, Minnesota, 55905, USA.
Inna G
IG
Ovsyannikova
Mayo Clinic Vaccine Research Group, Mayo Clinic, Guggenheim 611C, 200 1st Street S.W., Rochester, Minnesota, 55905, USA.
Hannah M
HM
Salk
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
Beth R
BR
Larrabee
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
V Shane
VS
Pankratz
Mayo Clinic Vaccine Research Group, Mayo Clinic, Guggenheim 611C, 200 1st Street S.W., Rochester, Minnesota, 55905, USA. poland.gregory@mayo.edu.
Gregory A
GA
Poland
D056704:Adaptive Immunity / Q000235:genetics / Q000276:immunology*; D000293:Adolescent; D057134:Antibodies, Neutralizing / Q000276:immunology; D000914:Antibodies, Viral / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000235:genetics / Q000276:immunology; D002648:Child; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005838:Genotype; D006239:Haplotypes / Q000276:immunology*; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology / Q000378:metabolism; D053710:Interleukin-10 Receptor beta Subunit / Q000235:genetics / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology / Q000378:metabolism; D008297:Male; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage / Q000276:immunology*; D015778:Minor Histocompatibility Antigens; D000075983:Nectins; D020641:Polymorphism, Single Nucleotide / Q000276:immunology*; D012097:Repressor Proteins / Q000235:genetics / Q000276:immunology; D012409:Rubella / Q000235:genetics / Q000276:immunology* / Q000821:virology; D012412:Rubella virus / Q000276:immunology*; D051197:Toll-Like Receptor 4 / Q000235:genetics / Q000276:immunology; D000070584:Tripartite Motif Proteins; D055815:Young Adult
D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D015815:Cell Adhesion Molecules; C081846:IL10RB protein, human; D053710:Interleukin-10 Receptor beta Subunit; D015850:Interleukin-6; D022542:Measles-Mumps-Rubella Vaccine; D015778:Minor Histocompatibility Antigens; C000619010:NECTIN1 protein, human; C000619014:NECTIN3 protein, human; D000075983:Nectins; D012097:Repressor Proteins; C495345:TLR4 protein, human; C094314:TRIM22 protein, human; D051197:Toll-Like Receptor 4; D000070584:Tripartite Motif Proteins; D007371:Interferon-gamma
Cytokines; Genetic association; Neutralizing antibodies; Rubella vaccine; Single nucleotide polymorphisms (SNPs)